Starting with Stories of Success: The Initial Psychiatric Consultation

2013 ◽  
Author(s):  
SuEllen Hamkins
Keyword(s):  
Depressed Mood ◽  
Treatment Options ◽  
College Counseling ◽  
Well Being ◽  
Panic Attacks ◽  
Counseling Service ◽  
Psychiatric Consultation ◽  
Treatment Of Depression

If compassionate connection is the heart of narrative psychiatry, then eliciting healing stories is its soul. In narrative psychiatry, we begin seeking stories of strength and meaning from the very first appointment. As we listen to the story a patient brings to us, we also listen for the untold stories implicit in their narrative that may support their well-being. Fleshing out these stories, making them alive with detail, vivid with language and compelling with plot, strengthens them and gives them purchase to eclipse a disempowering, problem-dominated story. What we can know about a patient depends on what we are listening for. The openings for story development that we hear and the questions we ask in the first appointment lead to the cocreation of the narrative of the patient’s life that informs our understanding of the problem and our treatment options. By eliciting narratives that lead to a more nuanced, colorful, and balanced portrait of the patient and a more contextualized view of the problem, we can understand the nature of the problem and the patient with more depth, clarity and subtlety. Tall and thin with a short spiky haircut, and carrying a canvas messenger bag, Amanda Riley spoke earnestly when she first came in to see me for treatment of depression. A sophomore in college, she was mired in a story of how she was making bad decisions and wasn’t living her life right. Amanda had been referred to me by a psychotherapist at the college counseling service where I consulted due to concerns about panic attacks and depressed mood. The hope was that I would be able to help Amanda clarify the nature of the problem and determine if medication might be helpful, a typical workaday situation for many psychiatrists in today’s world. So how would a narrative psychiatrist approach his or her first meeting with Amanda? At the start of my initial conversation with Amanda, I asked her what year of school she was in and what she was studying. She told me she was a sophomore in college, majoring in Chinese and art.

Diagnosis and Treatment of Depression During Pregnancy

CNS Spectrums ◽  
2004 ◽  
Vol 9 (3) ◽  
pp. 209-216 ◽  
Author(s):  
Lee S. Cohen ◽  
Ruta Nonacs ◽  
Adele C. Viguera ◽  
Alison Reminick
Keyword(s):  
Effective Treatment ◽  
Treatment Options ◽  
Well Being ◽  
Psychotropic Medications ◽  
Affective Distress ◽  
Treatment Of Depression ◽  
Potential Impact ◽  
Risk Of Treatment ◽  
Time Diagnosis ◽  
New Onset

ABSTRACTPregnancy has frequently been described as a time of affective well-being. However, a growing literature suggests that women are neither “protected” against new-onset or recurrence of depression during this time. Diagnosis and effective treatment of depression during pregnancy requires a careful weighing of risk of treatment which may include psychotropic medications against the risks associated with failure to adequately manage affective distress and its potential impact of maternal and fetal well-being. Treatment options during pregnancy are reviewed in the context of developing the most appropriate risk/benefit decision for individual patients with past or current depression who either anticipate pregnancy or who become pregnant.

Enhancing Student Well-Being through Animal Assisted Interventions in College Counseling Settings

2014 ◽  
Author(s):  
Aimee Adams ◽  
Rachel Daltry ◽  
Lisa House ◽  
Kristin Mehr ◽  
Anju Kaduvettoor Davidson
Keyword(s):  
College Counseling ◽  
Well Being

Considering a Potential Role of Linalool as a Mood Stabilizer for Bipolar Disorder

2020 ◽  
Vol 26 (40) ◽  
pp. 5128-5133
Author(s):  
Kate Levenberg ◽  
Wade Edris ◽  
Martha Levine ◽  
Daniel R. George
Keyword(s):  
Bipolar Disorder ◽  
Treatment Options ◽  
Mood Stabilizer ◽  
Well Being ◽  
Epidemiologic Studies ◽  
Treatment Regimens ◽  
Bipolar Spectrum Disorders ◽  
Short And Long Term

Epidemiologic studies suggest that the lifetime prevalence of bipolar spectrum disorders ranges from 2.8 to 6.5 percent of the population. To decrease morbidity and mortality associated with disease progression, pharmacologic intervention is indicated for the majority of these patients. While a number of effective treatment regimens exist, many conventional medications have significant side effect profiles that adversely impact patients’ short and long-term well-being. It is thus important to continue advancing and improving therapeutic options available to patients. This paper reviews the limitations of current treatments and examines the chemical compound Linalool, an alcohol found in many plant species, that may serve as an effective mood stabilizer. While relatively little is known about Linalool and bipolar disorder, the compound has been shown to have antiepileptic, anti-inflammatory, anxiolytic, anti-depressive, and neurotrophic effects, with mechanisms that are comparable to current bipolar disorder treatment options.

scholarly journals A Correlative Study Between Personality Traits and the Preference of Site Selection in Cosmetic Treatment

2021 ◽  
Vol 12 ◽  
Author(s):  
Huan Qian ◽  
Yuxiao Ling ◽  
Chen Wang ◽  
Cameron Lenahan ◽  
Mengwen Zhang ◽  
...  
Keyword(s):  
Personality Traits ◽  
Cosmetic Surgery ◽  
Treatment Options ◽  
Well Being ◽  
The Body ◽  
Eysenck Personality Questionnaire ◽  
Body Parts ◽  
Personality Profiles ◽  
Cross Sectional ◽  
Face Contour

Background: Cosmetic treatment was closely associated with beauty seekers' psychological well-being. Patients who seek cosmetic surgery often show anxiety. Nevertheless, not much is known regarding how personality traits relate to the selection of body parts that receive cosmetic treatment.Aims: This study aims to investigate the correlation between personality traits and various selection sites for cosmetic treatment via Eysenck Personality Questionnaire (EPQ).Methods: A cross-sectional approach was adopted to randomly recruited patients from a general hospital planning to undergo cosmetic treatments. All respondents completed the EPQ and provided their demographic information. The EPQ involves four scales: the extraversion (E), neuroticism (N), psychoticism (P), and lying scales (L). Psychological scales were evaluated to verify that people who selected different body sites for cosmetic intervention possessed different personality portraits.Results: A total of 426 patients with an average age of 32.14 ± 8.06 were enrolled. Among them, 384 were females, accounting for more than 90% of patients. Five treatment sites were analyzed, including the body, eye, face contour, nose, and skin. Comparatively, patients with neuroticism were more likely to undergo and demand rhinoplasty (OR 1.15, 95% CI 1.07–1.24, P < 0.001). Face contour treatment was commonly associated with extraversion (OR 1.05, 95% CI 1.00–1.11, P = 0.044), psychoticism (OR 1.13, CI 1.03–1.25, P = 0.013), and neuroticism (OR 1.05, CI 1.01–1.10, P = 0.019).Conclusions: This novel study attempted to determine the personality profiles of beauty seekers. The corresponding assessments may provide references for clinical treatment options and enhance postoperative satisfaction for both practitioners and patients.

The brain metastasis journey: Experience from patient, caregiver, and physician surveys on diagnosis and treatment of brain metastases.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e14004-e14004
Author(s):  
Albert Eusik Kim ◽  
GI-Ming WANG ◽  
Kristin A Waite ◽  
Scott Elder ◽  
Avery Fine ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Clinical Trials ◽  
Brain Metastases ◽  
Checkpoint Inhibitors ◽  
Treatment Options ◽  
Whole Brain Radiotherapy ◽  
Well Being ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Brain Radiotherapy

e14004 Background: Brain metastases (BM) is one of the most feared complications of cancer due to substantial neurologic sequalae, neuro-cognitive morbidity and grim prognosis. In the past decade, targeted therapies and checkpoint inhibitors have resulted in meaningfully improved overall survival for a minority of these patients. Accordingly, there is a growing need to identify issues surrounding patient survivorship and to standardize physician practice patterns for these patients. To date, there has not been a well-conducted formal study to specifically explore these questions of survivorship and practice standardization for BM patients. Methods: Here, we present results from a cross-sectional survey in which we analyzed responses from 237 BM patients, 209 caregivers, and 239 physicians. Surveys contained questions about BM symptoms, discussion of BM diagnosis by the clinician, psychosocial concerns, available treatment options for BM, BM patient advocacy resources, and BM-specific clinical trials. Results: Our survey revealed compelling findings about current care of BM patients. There were discrepancies in the perceived discussion of the implications of the diagnosis of BM, from the patient/caregiver and physician perspective. Important topics, such as prognosis and worrisome symptoms, were felt to have been discussed more frequently by physicians than by patients or caregivers. In our physician survey, private practice physicians, compared to academic physicians, were significantly more likely to recommend whole brain radiotherapy (61.1 vs 39.7%; p = 0.009). Participation in a clinical trial was one of the least recommended treatment options. Many physicians (59.1% private; 71.9% academic) stated that BM patients in their care are denied participation in a clinical trial, specifically due to the presence of BM. The consensus among physicians, patients and caregivers was that the highest yield area for federal assistance is increased treatment and research funding for BM. Conclusions: Our hope is that these findings will serve as a basis for future quality improvement measures to enhance patient-physician communication and patient well-being, continuing medical education activities detailing latest advances in BM for oncologists, and lobbying efforts to the federal government in prioritizing BM research, clinical trials, and patient survivorship.

scholarly journals The Integrative Psychiatry Curriculum: Development of an Innovative Model

2019 ◽  
Vol 8 ◽  
pp. 216495611984711
Author(s):  
Noshene Ranjbar ◽  
Mari Ricker ◽  
Amelia Villagomez
Keyword(s):  
Online Courses ◽  
Training Programs ◽  
Treatment Options ◽  
Well Being ◽  
Evidence Base ◽  
Self Awareness ◽  
Group Setting ◽  
Whole Person ◽  
Treatment Plans ◽  
Integrative Psychiatry

The Integrative Psychiatry Curriculum (IPC) was developed to train psychiatry residents and fellows to apply an Integrative Medicine (IM) approach for patients presenting with psychiatric disorders. Launched in 2015, IPC includes interactive online courses, in-person experiential sessions, and a clinical component with supervision. Twenty-one residents and fellows have completed the curriculum. The purpose of the IPC is 2-fold: to enhance patient wellness through training residents and fellows in evidence-based whole-person care and to improve physician well-being through enhanced stress management and self-awareness utilizing the practice of mind–body skills within a supportive small group setting. Course participants are trained in a broad range of prevention and treatment options and learn about their evidence base; they then practice incorporating IM into diagnosis and treatment plans through supervised clinical experience. This article describes the development of IPC and its elements. Efforts are underway to further develop and standardize the offerings and increase the portability of the course, making it easier for Psychiatry training programs with limited faculty expertise in IM to provide the curriculum for residents and fellows. To reach the goal of disseminating such a curriculum for integrative psychiatry, further funding and collaboration with multiple residency training programs is needed.

scholarly journals MEDICINAL HERBS AND PHYTOCHEMICALS USED IN THE TREATMENT OF DEPRESSION: A REVIEW

2019 ◽  
pp. 8-14
Author(s):  
APOORVA HA ◽  
SEEMA MEHDI ◽  
KRISHNA KL ◽  
NABEEL K
Keyword(s):  
Side Effects ◽  
Adverse Effects ◽  
Clinical Evidence ◽  
Emotional State ◽  
Well Being ◽  
New Approach ◽  
Treatment Of Depression ◽  
Primary Hypothesis ◽  
The Brain ◽  
Additional Option

Depression is a condition of no mood and loss of interest in any activity that can diminish a person’s thinking, conduct, tendencies, emotional state, and a sense of well-being. Although there is a conventional class of medication which have been beneficial in the treatment of depression, current studies have reported having side effects which can be minimized by the intervention of herbs and phytochemicals. Most of the studies have proven the various mechanisms and have started to research a very ground-breaking method by glancing the ancient treatmen. Where this new approach of using the herbs and phytochemicals has shown better results alone and in combination with conventional drugs which has shown lesser adverse effects. The practice of phytomedicine is an additional option for the treatment of depression. In the various segments of treating the depression, the mainstream can be a breakthrough including phytoconstituents. In this aspect, there are many contributions for the treatment of the depression acting to the neuronal level signaling and the phytoconstituents also have shown some basic mechanisms in the treatment of depression as that of the conventional medications following some primary hypothesis and signaling pathways and life interactions that effects the brain in either way to treat the depression in all sort of way. Clinical evidence is required to provide backing to the safety and effectiveness of herbs and phytochemicals alone or in combination with currently available drugs to overcome the reported side effects during the treatment of depression.

scholarly journals Dietary Treatment Options for Depression among Diabetic Patient, Focusing on Macronutrients

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Fahimeh Haghighatdoost ◽  
Leila Azadbakht
Keyword(s):  
Diabetes Complications ◽  
Heart Diseases ◽  
Treatment Options ◽  
Dietary Treatment ◽  
Renal Diseases ◽  
Diabetic Patients ◽  
Dietary Recommendations ◽  
Coronary Heart Diseases ◽  
Treatment Of Depression ◽  
Onset Of Diabetes

There is a bidirectional adverse association between diabetes and depression. The odds for experiencing depressive symptoms in diabetic patients are two times more than nondiabetic persons, and depression is an independent predictor for the onset of diabetes. However, depression has been approximately unrecognized and untreated in two-thirds of diabetic patients, which may lead to worsened diabetes complications. A cornerstone strategy for managing depression among diabetic patients is the use of diet to improve both health problems. Because of similar pathophysiology for chronic diseases and depression, it seems that similar dietary recommendations could be useful. However, few studies have been conducted among diabetic patients. Regarding the complications of diabetes such as renal diseases and coronary heart diseases, the proper range of various macronutrients should be clarified in depressed diabetic patients as well as the proper type of each macronutrient. In this paper, we reviewed the available data on the treatment of depression in diabetic patients.

scholarly journals Treatments recommended by health shops for symptoms of depression

2006 ◽  
Vol 30 (10) ◽  
pp. 365-368 ◽  
Author(s):  
Joyce E. Reed ◽  
Peter Trigwell
Keyword(s):  
Hypericum Perforatum ◽  
Participant Observation ◽  
Treatment Options ◽  
Evidence Base ◽  
Symptoms Of Depression ◽  
Moderate Depression ◽  
Treatment Of Depression ◽  
Wide Range ◽  
Herbal Medicinal ◽  
Firm Evidence

Aims and MethodWe assessed the appropriateness of treatments recommended by health shop staff for symptoms of mild-to-moderate depression using participant observation with ten members of staff from ten different health shops selling herbal medicinal preparations.ResultsA wide range of treatment options were suggested by health shop staff when presented with common symptoms of depression. The majority have no firm evidence base, with the exception of St John's wort (Hypericum perforatum).Clinical ImplicationsMost alternative treatments recommended by health shops for the treatment of depression have a poor evidence base. Implications for training and communication between agencies are discussed.

Sign in / Sign up

Export Citation Format

Share Document